SRD5A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.452800E-01
Normal-vs-Stage2
3.372000E-01
Normal-vs-Stage3
5.558200E-01
Normal-vs-Stage4
1.584590E-01
Stage1-vs-Stage2
3.298000E-01
Stage1-vs-Stage3
6.287200E-01
Stage1-vs-Stage4
4.735600E-01
Stage2-vs-Stage3
8.370000E-01
Stage2-vs-Stage4
8.328800E-01
Stage3-vs-Stage4
9.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.957400E-01
Normal-vs-AfricanAmerican
3.514600E-01
Normal-vs-Asian
3.221200E-01
Caucasian-vs-AfricanAmerican
8.799800E-01
Caucasian-vs-Asian
9.218200E-02
AfricanAmerican-vs-Asian
4.637800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.450400E-01
Normal-vs-Female
4.297800E-01
Male-vs-Female
7.752400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.852800E-01
Normal-vs-Age(41-60Yrs)
2.002000E-01
Normal-vs-Age(61-80Yrs)
4.965200E-01
Normal-vs-Age(81-100Yrs)
3.885600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.158600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.621600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.813400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.847500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.521400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.723800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.886200E-01
Normal-vs-Daily Drinker
3.982400E-01
Normal-vs-Weekly Drinker
3.385000E-01
Normal-vs-Occasional Drinker
2.825000E-01
Normal-vs-Social Drinker
2.636600E-01
Non Drinker-vs-Daily Drinker
9.959400E-01
Non Drinker-vs-Weekly Drinker
5.288200E-01
Non Drinker-vs-Occasional Drinker
7.620500E-02
Non Drinker-vs-Social Drinker
6.684600E-01
Daily Drinker-vs-Weekly Drinker
5.069400E-01
Daily Drinker-vs-Occasional Drinker
7.520000E-02
Daily Drinker-vs-Social Drinker
6.386800E-01
Weekly Drinker-vs-Occasional Drinker
1.779610E-01
Weekly Drinker-vs-Social Drinker
8.112000E-01
Occasional Drinker-vs-Social Drinker
1.204350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.490800E-01
Normal-vs-Grade 2
8.220600E-01
Normal-vs-Grade 3
8.910000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.739800E-01
Grade 1-vs-Grade 3
4.823600E-01
Grade 1-vs-Grade 4
6.490800E-01
Grade 2-vs-Grade 3
1.462210E-01
Grade 2-vs-Grade 4
8.220600E-01
Grade 3-vs-Grade 4
8.910000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.873800E-01
Normal-vs-NonDiabetic
3.625600E-01
Diabetic-vs-NonDiabetic
4.167700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.298800E-01
Normal-vs-NoPancreatitis
3.968600E-01
Pancreatitis-vs-NoPancreatitis
4.251600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.573200E-01
Normal-vs-N1
3.385000E-01
N0-vs-N1
6.392600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.127150E-01
Normal-vs-TP53-NonMutant
1.063590E-01
TP53-Mutant-vs-TP53-NonMutant
4.776600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
